Sign In
Buy UTHR
$549.47
+9.42 (+1.74%)
At Close: Jun 03, 2026
UTHR or ZTS: Which Is the Better Value Stock Right Now?
12:46pm, Friday, 02'nd Aug 2024
Investors with an interest in Medical - Drugs stocks have likely encountered both United Therapeutics (UTHR) and Zoetis (ZTS). But which of these two stocks presents investors with the better value op
Here's Why United Therapeutics (UTHR) is a Strong Growth Stock
10:46am, Friday, 02'nd Aug 2024
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
3 Reasons Why Growth Investors Shouldn't Overlook United Therapeutics (UTHR)
01:46pm, Wednesday, 31'st Jul 2024
United Therapeutics (UTHR) could produce exceptional returns because of its solid growth attributes.
United Therapeutics Corporation (UTHR) Q2 2024 Earnings Call Transcript
11:28am, Wednesday, 31'st Jul 2024
United Therapeutics Corporation (NASDAQ:UTHR ) Q2 2024 Earnings Conference Call July 31, 2024 9:00 AM ET Company Participants Dewey Steadman - Head of Investor Relations Martine Rothblatt - Chairperso
United Therapeutics (UTHR) Q2 Earnings Lag, Sales Top Estimates
10:56am, Wednesday, 31'st Jul 2024
United Therapeutics (UTHR) reports mixed second-quarter 2024 results. Tyvaso sales continue to drive the company's top line.
Here's Why United Therapeutics (UTHR) is a Strong Momentum Stock
10:50am, Wednesday, 31'st Jul 2024
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
United Therapeutics (UTHR) Reports Q2 Earnings: What Key Metrics Have to Say
10:36am, Wednesday, 31'st Jul 2024
Although the revenue and EPS for United Therapeutics (UTHR) give a sense of how its business performed in the quarter ended June 2024, it might be worth considering how some key metrics compare with W
United Therapeutics (UTHR) Misses Q2 Earnings Estimates
08:41am, Wednesday, 31'st Jul 2024
United Therapeutics (UTHR) came out with quarterly earnings of $5.85 per share, missing the Zacks Consensus Estimate of $6.33 per share. This compares to earnings of $5.24 per share a year ago.
Here's Why United Therapeutics (UTHR) is a Strong Value Stock
10:41am, Tuesday, 30'th Jul 2024
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
The 3 Best 3D Bioprinting Stocks to Buy Now
06:52am, Friday, 26'th Jul 2024
Investing in 3D bioprinting stocks is a highly speculative and specialized approach to the biotech industry in general. That's because it blends two relatively niche technologies to create a broader a
3 Biotech Stocks You Should Know About
02:35pm, Wednesday, 17'th Jul 2024
In June, we profiled biotech exchange-traded fund (ETF) SPDR S&P Biotech ETF (XBI) amid a historically bullish month.
UTHR vs. CTLT: Which Stock Is the Better Value Option?
12:46pm, Wednesday, 17'th Jul 2024
Investors interested in Medical - Drugs stocks are likely familiar with United Therapeutics (UTHR) and Catalent (CTLT). But which of these two companies is the best option for those looking for underv
Why United Therapeutics (UTHR) is a Top Growth Stock for the Long-Term
10:51am, Wednesday, 17'th Jul 2024
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
UTHR vs. CTLT: Which Stock Should Value Investors Buy Now?
12:46pm, Tuesday, 16'th Jul 2024
Investors with an interest in Medical - Drugs stocks have likely encountered both United Therapeutics (UTHR) and Catalent (CTLT). But which of these two stocks offers value investors a better bang for
5 High ROE Stocks to Buy as Low Inflation Fuels Rate Cut Hopes
08:26am, Tuesday, 16'th Jul 2024
United Therapeutics (UTHR), ABB (ABBNY), Lockheed Martin (LMT), MPLX (MPLX) and Banco de Chile (BCH) are some of the stocks with high ROE to profit from as easing inflationary pressures ignite rate cu
